Depression

Top Story

Glycemic variability tied to depressive symptoms in diabetes

June 22, 2017

Older adults with type 2 diabetes have an increased risk for higher depressive symptoms with greater variability in glycemic control whereas mean HbA1c does not affect depressive symptoms, according to study findings published in Diabetes Care.

Ramit Ravona-Springer, MD, an instructor at The Joseph Sagol Neuroscience Center at Sheba Medical Center and Sackler Faculty of Medicine at Tel Aviv University, both in Israel, and colleagues evaluated data from the Israel Diabetes and Cognitive Decline study on 837 adults (mean age, 72.74 years) with type 2 diabetes (mean HbA1c, 6.82%) to determine the relationship of variability in HbA1c since 1998 with subsequent depressive symptoms.

In the Journals

Microvascular dysfunction may increase risk for late-life depression

June 22, 2017
Peripheral and cerebral forms of microvascular dysfunction were associated with increased risk for depression, according to recent findings. “Evidence suggests a…
In the Journals

Probiotic improves depression, quality of life in IBS

June 19, 2017
The probiotic Bifidobacterium longum improved depression and quality of life, but not anxiety, among individuals with irritable bowel syndrome. “This study shows…
In the Journals

Brexanolone improves severe postpartum depression

June 15, 2017
Receiving an IV dose of brexanolone for 60 hours significantly improved depression among women with severe postpartum depression, compared with placebo, according to…
CME Article

Evidence-Based Treatment of Emotional Distress in Patients with Ischemic Coronary Heart Disease

Psychiatric Annals, December 2016, Volume 46 Issue 12
Replicated gold-standard evidence (ie, randomly assigned, controlled clinical trials) demonstrates that…
More »
CNE

Journal of Psychosocial Nursing and Mental Health Services September 2016 CNE Activity

This activity is co-provided by Villanova University College of Nursing and SLACK Incorporated.

Topics include managing workplace violence, complex working conditions in forensic psychiatric settings, and…
More »
Featured
American Psychiatric Association Annual Meeting

American Psychiatric Association Annual Meeting

Video
Meeting News Coverage

VIDEO: Treatment approaches for co-occurring substance use, psychiatric disorders

June 10, 2016
More »
In the Journals Plus

Glycemic variability tied to depressive symptoms in diabetes

June 22, 2017
Older adults with type 2 diabetes have an increased risk for higher depressive symptoms with greater variability in glycemic control whereas mean…

In the Journals

Microvascular dysfunction may increase risk for late-life depression

June 22, 2017
Peripheral and cerebral forms of microvascular dysfunction were associated with increased risk for depression, according to recent findings…

In the Journals

Probiotic improves depression, quality of life in IBS

June 19, 2017
The probiotic Bifidobacterium longum improved depression and quality of life, but not anxiety, among individuals with irritable bowel syndrome. …

In the Journals

Brexanolone improves severe postpartum depression

June 15, 2017
Receiving an IV dose of brexanolone for 60 hours significantly improved depression among women with severe postpartum depression, compared with…

In the Journals

Childhood chronic illness increases risk for adult depression, anxiety

June 15, 2017
Chronic physical illness in childhood was associated with increased risk for depression and anxiety in adulthood, particularly childhood cancer. …

In the Journals

Head Start strategy effective for maternal depression prevention

June 14, 2017
A problem-solving education intervention was effective in preventing depressive episodes among low-income and minority mothers with depressive…

In the Journals

Link between prenatal antidepressant use, ADHD risk may be overestimated

June 14, 2017
Prenatal antidepressant use and risk for ADHD may be partially due to confounding by indication of antidepressants, according to recent findings…

FDA grants Fast Track Designation to SAGE-217 for MDD

June 13, 2017
Sage Therapeutics recently received Fast Track Designation from the FDA for development of SAGE-217 as a potential treatment for major depressive…

App links keystrokes with manic, depressive episodes in bipolar disorder

June 12, 2017
BiAffect, an app that monitors mobile device usage to predict manic and depressive episodes in bipolar disorder, recently won the Mood Challenge for…

Treatment rates low for substance use disorders in US

June 12, 2017
Findings in a SAMHSA report indicated approximately 4% of individuals with an alcohol use disorder received specialty treatment for the disorder in…

More Headlines »
Advertisement
Advertisement